G-protein function is reduced in hypertension

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 422-427

  Feldman, Ross D ^a   Chorazyczewski, Jozef ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

adenylyl cyclase; adrenoceptors; G proteins

Indexed keywords

ADENYLATE CYCLASE; ADRENERGIC RECEPTOR; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; AGING; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPERTENSION; LYMPHOCYTE; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

EID: 0031017197     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.422     Document Type: Article

References (38)

1. Feldman RD. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest. 1990;5:647-652.
2. Buhler FR, Bolli P. Changes in cardiovascular responsiveness caused by age and high blood pressure: implications tor therapy. J Cardiovasc Pharmacol. 1985;7(suppl 3):S206-S215.
3. Feldman RD, Freeman DJ, Bierbrier GS, Anthony SE, Brown JE. β-Adrenersic responsiveness is regulated selectively in hypertension. Clin Pharmacol Ther. 1993;54:654-660.
4. Naslund T, Silberstein DJ, Merrell WJ, Nadeau JH, Wood AJJ. Low sodium intake corrects abnormality in β-receptor-mediated arterial vasodilation in patients with hypertension: correlation with β-receptor function in vitro. Clin Pharmacol Ther. 1990; 48:87-95.
5. Stein CM, Nelson R, Deegan R, Huaibing H, Wood M, Wood AJ. Forearm β-adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest. 1995;96:579-585.
6. Van Brummelen P, Buhler FR, Kiowski W, Amann FW. Age-related decrease in cardiac and peripheral vascular responsiveness to isoproterenol: studies in normal subjects. Clin Sci. 1981; 60:571-577.
7. Pan HYM, Hoffman BB, Pershe RA, Blaschke TF. Decline in β-adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther. 1986;239:802-807.
8. Feldman RD. A low-sodium diet corrects the defect in β-adrenergic response in older subjects. Circulation. 1992;85:612-618.
9. Klein C, Hiatt WR, Gerber JG, Nies AS. Age does not alter human vascular and nonvascular beta-2 adrenergic response to isoproterenol. Clin Pharmacol Ther. 1988;44:573-578.
10. Linder ME, Gilman AG. G proteins. Sci Am. 1992;267:56-65.
11. Hepler JR, Gilman AG. G proteins. Trends Biochem Sci. 1992;17: 383-387.
12. Feldman RD, Lawton WJ, McArdle WL. Low sodium diet corrects the defect in lymphocyte β-adrenergic responsiveness in hypertensive subjects. J Clin Invest. 1987;79:290-294.
13. Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJJ. Leukocyte β-receptor alterations in hypertensive subjects. J Clin Invest. 1984;73:648-653.
14. Brodde O-E, Michel MC. Adrenergic receptors and their signal transduction mechanisms in hypertension. J Hypertens. 1992;10(suppl 7):S133-S145.
15. Insel PA. Adrenergic receptors, G proteins, and cell regulation: implications for aging research. Exp Gerontol. 1993;28:341-348.
16. Feldman RD. Physiological and molecular correlates of age-related changes in the human β-adrenergic receptor system. Fed Proc. 1986; 45:48-50.
17. 2-adrenergic receptors. Hypertension. 1995;25: 88-91.
18. Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJJ. Alterations in leukocyte β-receptor affinity with aging: a potential explanation for altered β-adrenergic sensitivity in the elderly. N Engl J Med. 1984;310:815-819.
19. Montamat SC, Davies AO. Physiological response to isoproterenol and coupling of beta-adrenergic receptors in young and elderly human subjects. J Gerontol Med Sci. 1989;44: M100-M105.
20. Zahniser NR, Parker DC, Bier-Laning CM, Miller JA, Gerber JG, Nies AS. Comparison between the effects of aging on antagonist and agonist interactions with beta-adrenergic receptors on human mononuclear and polymorphonuclear leukocyte membranes. J Gerontol. 1988;43:M151-M157.
21. Yoshikawa H, Fukuda K, Wanaka Y, Kasamatsu K, Baba A, Nishio I, Masuyama Y. Deficient activity of stimulatory nucleotide-binding regulatory protein in lymphocytes from patients with essential hypertension. Am J Hypertens. 1994;7:713-716.
22. Feldman RD, Tan CM, Chorazyczewski J. G-protein alterations in hypertension and aging. Hypertension. 1995;26:725-728.
23. 2+ inhibition of type III adenylyl cyclase in vivo. J Biol Chem. 1995;37:21480-21486.
24. Pieroni JP, Harry A, Chen J, Jacobowitz O, Magnusson RP, Iyengar R. Distinct characteristics of the basal activities of adenylyl cyclases 2 and 6. J Biol Chem. 1995;36:21368-21373.
25. Post SR, Aguila-Buhain O, Insel PA. A key role for protein kinase A in homologous desensitization of the beta 2-adrenergic receptor pathway in S49 lymphoma cells. J Biol Chem. 1996;27: 895-900.
26. 3H]Forskolin binding to cardiac adenylate cyclase in guinea pigs chronically infused with isoproterenol. Life Sci. 1995;57:1039-1049.
27. Kim GD, Carr IC, Milligan G. Detection and analysis of agonist-induced formation of the complex of the stimulatory guanine nucleotide-binding protein with adenylate cyclase in intact wild-type and beta 2-adrenoceptor-expressing NG108-15 cells. Biochem J. 1995; 308:275-281.
28. Leiber D, Jasper JR, Alousi AA, Martin J, Berstein D, Insel PA. Alterations in Gs-mediated signal transduction in S49 lymphoma cells treated with inhibitors of microtubules. J Biol Chem. 1993; 268:3833-3837.
29. 3H]forskolin binding to human platelet membranes by GppNHp, NaF, and prostaglandin E1. FEBS Lett. 1985;183:349-352.
30. 3H]forskolin binding to rat cerebral cortical membrane. Prog Neuropsychopharmacol Biol Psychiatry. 1991;15:709-716.
31. Darfler FJ, Maban LC, Koachman AM, Insel PA. Stimulation by forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. J Biol Chem. 1982;257:11901-11907.
32. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 1968;21:77-89.
33. Carpentieri U, Minguell JJ, Gardner FH. Adenylate cyclase and guanylate cyclase activity in normal and leukemic human lymphocytes. Blood. 1981;57:975-978.
34. Mendelsohn J, Nordberg J. Adenylate cyclase in thymus-derived and bone marrow-derived lymphocytes from normal donors and patients with chronic lymphocytic leukemia. J Clin Invest. 1979;65: 1124-1132.
35. Hancock AA, Bush EN, Stanisic D, Kyncl JJ, Lin CT. Data normalization before statistical analysis: keeping the horse before the cart. Trends Pharmacol Sci. 1988;9:29-32.
36. Laurenza A, Sutkowski EM, Seamon KB. Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action. Trends Pharmacol Sci. 1989;10:442-446.
37. Tan CM, Xenoyannis S, Feldman RD. Oxidant stress enhances adenylyl cyclase activation. Circ Res. 1995;77:710-717.
38. Applegate WB. Hypertension in elderly patients. Ann Intern Med. 1989;110:910-915.